Surgery Partners, Inc. has announced a significant amendment to its merger agreement with Spyglass Topco, LLC, which could reshape its future and impact the broader healthcare industry.

On November 8, 2026, Surgery Partners entered into Amendment No. 1 to its Agreement and Plan of Merger with Spyglass Topco. This amendment increases the cash consideration for each share of Surgery Partners' common stock to $25.00, excluding rollover shares. Additionally, if the merger does not close by March 1, 2027, shareholders will receive a monthly 'ticking fee' of 10% per annum on the merger consideration until the deal is finalized.

Background

Surgery Partners, Inc., incorporated in Delaware, operates within the healthcare sector, specifically classified under SIC 8062, which includes services related to general medical and surgical hospitals. The company trades on the Nasdaq under the ticker symbol SGRY. It has been active in the market with several recent filings, including a current report on Form 8-K and multiple DEFA14A submissions.

What the Filing Says

The filing details that the amendment not only increases the cash offer but also outlines provisions for corresponding cash payments related to outstanding company stock options and restricted stock. It emphasizes the necessity for Parent to take all actions required to eliminate any regulatory hurdles that could delay the merger.

Impact

This amendment is likely to affect Surgery Partners' shareholders significantly, as the increased cash offer and ticking fee provide a more attractive exit strategy. Additionally, the changes may influence competitors in the healthcare sector to reconsider their merger and acquisition strategies, particularly in light of the heightened cash offer and regulatory commitments.

What's Next

The filing does not specify what happens next, but it indicates that Surgery Partners will continue to pursue the necessary approvals to finalize the merger. Shareholders are encouraged to review the upcoming proxy statement related to the merger for more detailed information.